Related Experiment Video
Updated: Jul 16, 2026

Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
Long-term outcome in patients with juvenile dermatomyositis: A case series
G Chevalier1, O Fakih2, A Lhose3
1Service de Dermatologie, Inserm 1098 RIGHT, Université de Franche Comté, Centre Hospitalier Universitaire, 3, boulevard Fleming, 25030 Besançon, France.
Insights
Juvenile dermatomyositis (JDM) patients show good long-term functional outcomes, with minimal skin and muscle damage after extended follow-up. Most patients maintain normal muscle strength and experience mild disability, indicating a positive prognosis for JDM.
Area of Science:
- Rheumatology
- Pediatric Autoimmunity
- Dermatology
Background:
- Juvenile dermatomyositis (JDM) is a rare autoimmune disease affecting children, with known long-term impacts on multiple organs.
- Limited data exists on the long-term prognosis and outcomes for JDM patients.
Purpose of the Study:
- To assess the long-term outcomes in a cohort of juvenile dermatomyositis patients.
- To evaluate the persistent effects of JDM on skin, muscles, and overall patient well-being.
Main Methods:
- A cohort of JDM patients underwent detailed assessments by dermatologists and rheumatologists.
- Validated tools including aCAT, MMT8, CMAS, MDI, CHAQ, and HAQ were used to evaluate disease activity, muscle strength, damage, and disability.
- Long-term outcomes such as growth, puberty, education, vocation, and comorbidities were recorded.
Main Results:
- After a mean follow-up of 14.9 years, most patients (71%) showed minimal active skin disease (aCAT score) and significant skin damage (MDI).
- The majority of patients (71.4%) exhibited normal muscle strength (MMT8 >72), with no severe muscle weakness reported.
- Disability was mild (CHAQ/HAQ index) in 29% of patients, and quality of life scores were generally favorable.
Conclusions:
- Long-term follow-up using validated cutaneous and musculoskeletal scores indicates favorable functional outcomes for juvenile dermatomyositis patients.
- The study suggests that while some long-term damage may persist, JDM patients generally achieve good functional recovery and quality of life.
Background:
Follow-up of juvenile dermatomyositis (JDM) patients has demonstrated the impact of the disease on several organs in the long term.
Objective:
As there is little information on the long-term outcome of JDM, we aimed to assess long-term outcomes in a series of JDM patients.
Methods:
After selection of JDM patients, a consultation with a dermatologist and a rheumatologist was held for each patient. Cutaneous, muscle, and disease damage was assessed using different validated scores including the abbreviated Cutaneous Assessment Tool (aCAT), 8-muscle Manual Muscle Testing (MMT8), Childhood Myositis Assessment Scale (CMAS), Myositis Damage Index (MDI), Childhood Health Assessment Questionnaire (CHAQ), and Health Assessment Questionnaire (HAQ). Long-term disease outcomes were recorded including growth and pubertal development, educational and vocational achievement, and development of comorbidities.
Results:
Seven patients were included in the study. After a mean follow-up of 14.9±8.8 years, the mean aCAT score was 0.57±1.4 and only one patient had a positive aCAT activity score. The mean aCAT damage score was 1.4±1.3 and five (71%) patients had a score of ≥1. Five (71.4%) patients had normal muscle strength with an MMT8 score of >72, and none had severe muscle weakness (MMT8 ≤32, and CMAS<35). The mean total extent of damage according to the MDI was ≥1 in five (71%) patients and mainly involved the skin. Two (29%) patients had mild disability according to the CHAQ/HAQ disability index. In terms of quality of life, no patient had a score of<40 (1 SD below the mean for healthy controls).
Conclusions:
Based on validated cutaneous and musculoskeletal scores, our study demonstrated the good functional outcomes of JDM at long-term follow-up.
More Related Videos
Related Concept Videos
Papillary Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Nephrotic Syndrome II : Assessment and Medical Management

